Probiotics have shown promise in the prevention and management of chronic diseases due to their ability to modulate the gut microbiome and immune response. By enhancing gut health, probiotics can influence systemic inflammation and metabolic processes, potentially reducing the risk of conditions such as cardiovascular disease, diabetes, and certain cancers. They help maintain a balanced gut flora, which is crucial for regulating immune function and reducing inflammation. Additionally, probiotics can support metabolic health by improving insulin sensitivity and lowering cholesterol levels. Prebiotics, which nourish beneficial bacteria, complement the effects of probiotics by further promoting a healthy gut environment. Together, these microorganisms contribute to a robust defense system and may play a significant role in preventing chronic diseases and improving overall health outcomes.
Title : Results from a cross-sectional observational study examining irritable bowel syndrome patients six months after finishing their participation in the ViIBS trial
Jacek Piatek, Calisia University, Poland
Title : Gut microbiome as a driver of healthy ageing
Thi Thu Hao Van, RMIT University, Australia
Title : Treating irritable bowel syndrome patients with a balanced multi-strain synbiotic–results from a multi-center, randomized, double-blind, placebo-controlled clinical trial (the ViIBS trial)
Henning Sommermeyer, Calisia University, Poland
Title : Molecular mechanisms underlying the anti-atherogenic actions of probiotics
Dipak P Ramji, Cardiff University, United Kingdom
Title : Global regulatory trends on the use of probiotics and prebiotics in foods and food supplements
David Pineda Ereno, DPE International Consulting, Belgium
Title : Biochemical profile and nutripotential glimpses of Terminalia arjuna bark extract
Suriyavathana Muthukrishnan, Periyar University, India